BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21793125)

  • 61. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation.
    Garrity-Park M; Loftus EV; Sandborn WJ; Smyrk TC
    Inflamm Bowel Dis; 2012 Feb; 18(2):275-83. PubMed ID: 21425209
    [TBL] [Abstract][Full Text] [Related]  

  • 63. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.
    Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
    Carcinogenesis; 2012 Oct; 33(10):1889-96. PubMed ID: 22739025
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.
    Gillespie E; Leeman SE; Watts LA; Coukos JA; O'Brien MJ; Cerda SR; Farraye FA; Stucchi AF; Becker JM
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17420-5. PubMed ID: 21969570
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma.
    Sato F; Shibata D; Harpaz N; Xu Y; Yin J; Mori Y; Wang S; Olaru A; Deacu E; Selaru FM; Kimos MC; Hytiroglou P; Young J; Leggett B; Gazdar AF; Toyooka S; Abraham JM; Meltzer SJ
    Cancer Res; 2002 Dec; 62(23):6820-2. PubMed ID: 12460892
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk.
    Suchy J; Kłujszo-Grabowska E; Kładny J; Cybulski C; Wokołorczyk D; Szymańska-Pasternak J; Kurzawski G; Scott RJ; Lubiński J
    BMC Cancer; 2008 Apr; 8():112. PubMed ID: 18433468
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
    Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
    Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis.
    Fujii S; Tominaga K; Kitajima K; Takeda J; Kusaka T; Fujita M; Ichikawa K; Tomita S; Ohkura Y; Ono Y; Imura J; Chiba T; Fujimori T
    Gut; 2005 Sep; 54(9):1287-92. PubMed ID: 15870230
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis.
    Kawamata S; Matsuzaki K; Murata M; Seki T; Matsuoka K; Iwao Y; Hibi T; Okazaki K
    Inflamm Bowel Dis; 2011 Mar; 17(3):683-95. PubMed ID: 20602465
    [TBL] [Abstract][Full Text] [Related]  

  • 70. NF-kappaB p65 antisense oligonucleotides may serve as a novel molecular approach for the treatment of patients with ulcerative colitis.
    Li Z; Zhang DK; Yi WQ; Ouyang Q; Chen YQ; Gan HT
    Arch Med Res; 2008 Nov; 39(8):729-34. PubMed ID: 18996285
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mitochondria and tumor progression in ulcerative colitis.
    Ussakli CH; Ebaee A; Binkley J; Brentnall TA; Emond MJ; Rabinovitch PS; Risques RA
    J Natl Cancer Inst; 2013 Aug; 105(16):1239-48. PubMed ID: 23852949
    [TBL] [Abstract][Full Text] [Related]  

  • 72. RUNX3 copy number predicts the development of UC-associated colorectal cancer.
    Watanabe T; Kobunai T; Ikeuchi H; Yamamoto Y; Matsuda K; Ishihara S; Nozawa K; Iinuma H; Kanazawa T; Tanaka T; Yokoyama T; Konishi T; Eshima K; Ajioka Y; Hibi T; Watanabe M; Muto T; Nagawa H
    Int J Oncol; 2011 Jan; 38(1):201-7. PubMed ID: 21109941
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic polymorphisms of
    Arisawa T; Nakamura M; Otsuka T; Jing W; Sakurai N; Takano H; Hayashi T; Ota M; Nomura T; Hayashi R; Shimasaki T; Tahara T; Shibata T
    World J Gastroenterol; 2017 Aug; 23(29):5364-5370. PubMed ID: 28839436
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models.
    Seril DN; Liao J; Yang GY; Yang CS
    Carcinogenesis; 2003 Mar; 24(3):353-62. PubMed ID: 12663492
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Analysis of fibroblast genes selected by NMF to reveal the potential crosstalk between ulcerative colitis and colorectal cancer.
    Boccarelli A; Del Buono N; Esposito F
    Exp Mol Pathol; 2021 Dec; 123():104713. PubMed ID: 34666047
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice.
    Chen M; Yi Y; Chen B; Zhang H; Dong M; Yuan L; Zhou H; Jiang H; Ma Z
    Toxicology; 2024 Mar; 503():153757. PubMed ID: 38364893
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional comparison between genes dysregulated in ulcerative colitis and colorectal carcinoma.
    Zhao W; Qi L; Qin Y; Wang H; Chen B; Wang R; Gu Y; Liu C; Wang C; Guo Z
    PLoS One; 2013; 8(8):e71989. PubMed ID: 23991021
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of ulcerative colitis with solute-linked carrier family 26 member A3 gene polymorphisms and its expression in colonic tissues in Chinese patients.
    Shao XX; Lin DP; Sun L; Wu CQ; Yang W; Jiang Y
    Int J Colorectal Dis; 2018 Sep; 33(9):1169-1172. PubMed ID: 29855681
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An Overview of Molecular Profiles in Ulcerative Colitis-Related Cancer.
    Xue M; Shi L; Wang W; Chen S; Wang L
    Inflamm Bowel Dis; 2018 Aug; 24(9):1883-1894. PubMed ID: 29945208
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combination Metabolomics Approach for Identifying Endogenous Substrates of Carnitine/Organic Cation Transporter OCTN1.
    Masuo Y; Ohba Y; Yamada K; Al-Shammari AH; Seba N; Nakamichi N; Ogihara T; Kunishima M; Kato Y
    Pharm Res; 2018 Oct; 35(11):224. PubMed ID: 30280275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.